These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Changes of the locomotor system in the course of progressive systemic sclerosis in children]. Szymańska-Jagiello W; Rondio H; Jakubowska K Pediatr Pol; 1970 Aug; 45(8):929-41. PubMed ID: 5469379 [No Abstract] [Full Text] [Related]
7. [Clinical and etiopathological appraisal of diffuse scleroderma with skin depigmentation]. Szczepański A Przegl Dermatol; 1973; 60(3):323-6. PubMed ID: 4542932 [No Abstract] [Full Text] [Related]
8. [Systemic sclerosis: a multisystem disease]. Berrevoets MA; Markhorst J; Meek I; van Ede AE; Vonk MC Ned Tijdschr Geneeskd; 2014; 158():A7703. PubMed ID: 25052356 [TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Poormoghim H; Lucas M; Fertig N; Medsger TA Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887 [TBL] [Abstract][Full Text] [Related]
12. [Osteoarthritic changes in scleroderma]. Kolár J; Drugová B; Stáva Z Fysiatr Revmatol Vestn; 1972 Apr; 50(2):78-83. PubMed ID: 5062987 [No Abstract] [Full Text] [Related]
13. Primary localised cutaneous amyloidosis in systemic sclerosis. Black MM Trans St Johns Hosp Dermatol Soc; 1971; 57(1):177-80. PubMed ID: 5570256 [No Abstract] [Full Text] [Related]
14. [Osseous, muscular and articular lesions in scleroderma]. Stoichita S; Safiresco T; Boicesco L; Brosteanu E; Steclaci A; Debau M; Marinesco E; Gavrila I; Gavrila D Przegl Dermatol; 1965; 52(3):243-9. PubMed ID: 5830798 [No Abstract] [Full Text] [Related]
15. Endothelin-1 and cold provocation in health, primary Raynaud's phenomenon, and progressive systemic sclerosis. Dörffler-Melly J; Lüscher TF; Wenk M; Wen S; Bollinger A; Franzeck UK Microvasc Res; 1996 Sep; 52(2):193-7. PubMed ID: 8901448 [No Abstract] [Full Text] [Related]
16. Systemic sclerosis with myocardial and pericardial involvement. Dilke TF; Richardson AT Proc R Soc Med; 1971 Jan; 64(1):57-8. PubMed ID: 4251653 [No Abstract] [Full Text] [Related]
17. Systemic sclerosis/scleroderma: a treatable multisystem disease. Hinchcliff M; Varga J Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma. Pauling JD; Gunawardena H; Coghlan JG; Easaw J; Suntharalingam J; McHugh NJ Rheumatology (Oxford); 2008 Sep; 47(9):1431-2. PubMed ID: 18603658 [No Abstract] [Full Text] [Related]
19. Increased plasma adrenomedullin concentrations in patients with Raynaud's phenomenon. Letizia C; Danese C; D'Erasmo E J Rheumatol; 1999 Mar; 26(3):759-60. PubMed ID: 10090204 [No Abstract] [Full Text] [Related]
20. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Gore J; Silver R Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356 [No Abstract] [Full Text] [Related] [Next] [New Search]